|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.37 USD | +0.64% |
|
+0.35% | -24.58% |
| May. 30 | Baird Starts Privia Health Group With Outperform Rating, $23 Price Target | MT |
| May. 20 | Barclays Adjusts Price Target on Privia Health to $19 From $22, Maintains Equalweight Rating | MT |
Privia Health Group, Inc. reiterated earnings guidance for the year 2024. For the period, the company expects GAAP revenue of $1,600 million to $1,675 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -24.58% | 2.07B | |
| +25.52% | 88.99B | |
| -24.52% | 74.82B | |
| -5.56% | 25.03B | |
| +4.31% | 17.88B | |
| -14.25% | 16.43B | |
| +2.97% | 15.77B | |
| +79.20% | 13.21B | |
| +70.11% | 13.09B | |
| +40.44% | 12.9B |
PRIVIA HEALTH GROUP, INC. 
